Istituto di Ricerca in Biomedicina

Institute for
Research
in Biomedicine

Contacts

Inside

News

Events

IRB Community

Support our research

USI-IRB-logo-ita-

Contatti

Inside

Notizie

Eventi

IRB Community

Supporta la nostra ricerca

Notizie

Engineered bacteria for cancer immunotherapy

Nuove sovvenzioni SNSF assegnate a tre ricercatori dell’IRB

First peptide inhibitor of the CXCL12/HMGB1 heterocomplex identified

È nata l’Associazione Bellinzona Institutes of Science (Bios+)

Verso la sperimentazione clinica dell’anticorpo sviluppato dall’IRB contro la COVID-19

A Single Vaccine Against Coronaviruses is a step closer

Liver disease associated to alpha1-antitrypsin deficiency: a paper by Molinari’s lab published in the EMBO Journal uncovers the signals encoding clearance of ATZ polymers

LICTOR, un nuovo potente strumento per prevenire l’amiloidosi sistemica a catena leggera

Prestigiosa nomina per Petr Cejka

Team di immunologi decifra il meccanismo di riconoscimento di SARS-CoV-2 da parte dei linfociti T CD4 in pazienti guariti da COVID-19

Consegnato al Prof. Antonio Lanzavecchia l’Ernst Jung Gold Medal for Medicine

New paper from the Cavalli’s lab: computational identification of an allosteric binding site in TMPRSS2

Institute for Research in Biomedicine

Istituto di Ricerca in Biomedicina

Via Francesco Chiesa 5
6500 Bellinzona, Switzerland 
Tel. +41 58 666 7000
Fax +41 

Stay in touch

Facebook / Twitter

© Istituto di Ricerca in Biomedicina

Solution by Latitude 46
News / Events / Research Groups / People / Teaching / About Us / Media and communications / Reports / How to support our research / Inside / Contact and directions
up